Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts
Xiaowen Huang(Shanghai Jiao Tong University), Haoyan Chen(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University), Hua Xiong(Shanghai Jiao Tong University), Jie Hong(Shanghai Jiao Tong University), Jinmei Ding(Shanghai Jiao Tong University), Xiaoqiang Zhu(Shanghai Jiao Tong University), Linhua Ji(Shanghai Jiao Tong University), Yanru Ma(Shanghai Jiao Tong University), Lijun Ning(Shanghai Institute of Hematology), Zhigang Guo(Nanjing Normal University), Yuqing Yan(Shanghai Jiao Tong University), Ying Zhao(Shanghai Jiao Tong University), Jiantao Li(Guangdong Ocean University), Youwei Zhang(Shanghai University), Jilin Wang(Shanghai Jiao Tong University), Tianying Tong(Shanghai Jiao Tong University), Muni Hu(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Tiantian Sun, Yilu Zhou(Shanghai Jiao Tong University)
Cited by 82
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
Roles of Chk1 in cell biology and cancer therapy
|International Journal of Cancer|2013|456
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
|Nature Communications|2023|231